Jacobs Levy Equity Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-471,977
| Closed | -$7.42M | – | 1077 |
|
|
2024
Q1 | $7.42M | Buy |
471,977
+47,936
| +11% | +$754K | 0.03% | 357 |
|
|
2023
Q4 | $6.84M | Sell |
424,041
-283,062
| -40% | -$4.57M | 0.03% | 367 |
|
|
2023
Q3 | $8.99M | Sell |
707,103
-148,172
| -17% | -$1.88M | 0.05% | 274 |
|
|
2023
Q2 | $12M | Sell |
855,275
-22,862
| -3% | -$322K | 0.07% | 252 |
|
|
2023
Q1 | $13.6M | Sell |
878,137
-341,943
| -28% | -$5.28M | 0.08% | 242 |
|
|
2022
Q4 | $20M | Sell |
1,220,080
-91,476
| -7% | -$1.5M | 0.14% | 191 |
|
|
2022
Q3 | $24.3M | Buy |
1,311,556
+112,547
| +9% | +$2.08M | 0.19% | 142 |
|
|
2022
Q2 | $15.8M | Buy |
1,199,009
+948,069
| +378% | +$12.5M | 0.12% | 202 |
|
|
2022
Q1 | $2.33M | Sell |
250,940
-1,077
| -0.4% | -$9.98K | 0.02% | 593 |
|
|
2021
Q4 | $2.46M | Buy |
252,017
+231,382
| +1,121% | +$2.26M | 0.02% | 578 |
|
|
2021
Q3 | $701K | Sell |
20,635
-55,937
| -73% | -$1.9M | ﹤0.01% | 815 |
|
|
2021
Q2 | $2.8M | Sell |
76,572
-35,411
| -32% | -$1.3M | 0.02% | 541 |
|
|
2021
Q1 | $5.02M | Buy |
111,983
+72,947
| +187% | +$3.27M | 0.04% | 416 |
|
|
2020
Q4 | $2.23M | Buy |
+39,036
| New | +$2.23M | 0.02% | 557 |
|